Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05265169 · ClinicalTrials.gov registry record · NA
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
A NA study of Colorectal Liver Metastases, sponsored by Society of Interventional Oncology.
- Recruiting
- Registry status
- NA
- Development phase
- 275
- Enrollment target
- 7
- Study locations
NCT05265169 is a NA study of Colorectal Liver Metastases that is actively recruiting participants, run by Society of Interventional Oncology. The registered enrollment target is 275 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT05265169, a NA study of Colorectal Liver Metastases, is actively recruiting participants, sponsored by Society of Interventional Oncology.
- RECRUITING
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
- 7
- Study locations
Study Summary
To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.
Conditions Studied
Interventions
- DEVICE Microwave ablation
Study Locations (7)
Other
- National and Kapodistrian University of Athens (NKUA) - Athens
- Amsterdam UMC - Amsterdam
Florida
- Miami Cancer Institute - Miami
Minnesota
- Mayo Clinic - Rochester
New York
- Memorial Sloan Kettering Cancer Center - New York
Texas
- MD Anderson Cancer Center - Houston
Wisconsin
- Medical College of WI - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2023-01-13 |
| Est. Completion | 2027-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05265169
The ClinicalTrials.gov registry entry for NCT05265169 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Society of Interventional Oncology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Liver Metastases appearing as the primary indexed condition, and to 1 intervention - of which Microwave ablation is the first listed.
NCT05265169 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Other, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05265169 about?
NCT05265169 is a clinical study titled "Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)". To demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.
What is the current status of trial NCT05265169?
This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2023-01-13. Estimated completion is 2027-12-10.
What conditions does trial NCT05265169 study?
This clinical trial studies the following conditions: Colorectal Liver Metastases.
What interventions are being tested in trial NCT05265169?
The interventions under investigation include: Microwave ablation (DEVICE).
Who is sponsoring clinical trial NCT05265169?
This trial is sponsored by Society of Interventional Oncology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05265169 being conducted?
This trial has 7 study locations across Florida, Minnesota, New York, Texas, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Liver Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.